• OPEN AN ACCOUNT
Indian Indices
Sensex
85,408.70 -116.14
( -0.14%)
Global Indices
Nasdaq
48,752.17 288.75
(0.60%)
Dow Jones
6,952.35 21.56
(0.31%)
Hang Seng
50,381.79 37.69
(0.07%)
Nikkei 225
9,870.68 -18.54
(-0.19%)
Forex
USD-INR
89.57 -0.04
(-0.05%)
EUR-INR
105.52 0.34
(0.32%)
GBP-INR
120.86 0.52
(0.43%)
JPY-INR
0.57 0.00
(0.60%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
461.79599
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
10.81
16410.94
EPS(TTM)
Face Value()
Div & Yield %
84.75
2
0.65
 

As on: Dec 24, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
2,742.65 76.20 37212 36.05
Stock Price Details
Open Price() 2,736.20
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 2,820.00
Today's Low () 2,714.85
52-Week High () 3115
152-Week Low () 2022.05
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 1.02
Eps 76.07
Book Value 330.3875196
Market Cap (.Cr) 34,265.47
Face Value 2
Market Lot 1
AGM Date Jul
Book Closure Date
ISIN No. INE031B01049


News
Volumes jump at JBM Auto Ltd counter
Volumes soar at Castrol India Ltd counter
Ajanta Pharma Ltd soars 0.12%, up for fifth straight session
Ajanta Pharma Ltd rises for third straight session
Ajanta Pharma Ltd - Ajanta Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Board of Ajanta Pharma recommends interim dividend
Ajanta Pharma consolidated net profit rises 20.19% in the September 2025 quarter
Ajanta Pharma fixes record date for 1st interim dividend
Ajanta Pharma gains after Q2 PAT jumps 20% YoY to Rs 260 cr; declares dividend of Rs 28/ share
Ajanta Pharma Ltd - Ajanta Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
More
Corporate Details
Incoporation Year   : 1979
Chairman : Mannalal B Agrawal
Bussiness Group : Indian Private
Registered Office
Ajanta Pharma Ltd
Ajanta House,
Charkop Kandivli (W),
Mumbai,
Maharashtra-400067
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-66061000/1204/1203
Fax:91-22-66061200/1300
Fax:91-22-66317458
E-Mail : info@ajantapharma.com; investorgrievance@ajantapha
URL : http://www.ajantapharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE Midcap
  • CNX 500
  • CNX Pharma
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi